More than 30 m people across the US are living with diabetes, and foot problems including foot ulcers are common complications that, without proper treatment, can lead to hospital admissions and even amputations.
The ADA Compendium was compiled by a panel of contributing authors and distributed this month to health care professionals who subscribe to the ADA's peer-reviewed journals Diabetes Care and Diabetes. Healogics is passionate about providing wound carefor the 25% of diabetics who will experience a foot ulcer at some point in their life.
The Compendium has been distributed to Healogics' 4,000 affiliated physicians and will be distributed to thousands more who entrust their patients care to Healogics Wound Care Centers across the country.
An estimated 15% of those with a diabetic foot ulcer will experience an amputation.
Over the past year, Healogics has sought to advance the science, awareness and practice of wound care through the Wound Science Initiative.
The Wound Science Initiative includes collaborations such as this one with advocacy organizations including the ADA and other academic and scientific leaders. Healogics seeks to unite and educate key stakeholders across the healthcare environment to ensure that chronic wound patients receive the highest quality evidence-based care.
These aims will be achieved by leveraging Healogics vast clinical database of over three m records to advance the science and practice of wound care through research, technology and collaboration.
Patients with an amputation have a 50% mortality rate within five years.
Healogics' support of the ADA includes advertising in print and digital publications, including Diabetes Care, Clinical Diabetes and Diabetes Forecast and events at future scientific symposiums.
Headquartered in Jacksonville, Fla., Healogics is the nation's wound healing expert. Last year over 330,000 patients received advanced wound care through a nationwide network of nearly 700 Wound Care Centers.
The Healogics team is made up of almost 3,000 employees, 4,000 affiliated physicians and a Healogics Specialty Physician practice group of nearly 300. In addition to the company's network of outpatient Centers, Healogics partners with over 300 skilled nursing facilities to care for patients with chronic wounds, and provides inpatient consults at more than 80 partner hospitals.
Galmed Pharmaceuticals reports topline results for combination of Aramchol, Stivarga and metformin
Adocia files patent for long-acting peptide platform AdoXLong and updates on BioChaperone studies
10XREVIV Launch Announced in Abu Dhabi Through Partnership Between 10X Health, REVIV Global and M42
Terns Pharmaceuticals reports topline 12-week data from Phase 2 trial of TERN-601 in obesity
Ascletis selects once-monthly SQ GLP-1R/GIPR dual peptide agonist, ASC35, for clinical development
Celltrion's biosimilar EYDENZELT (aflibercept-boav) approved by US FDA
Novo Nordisk to acquire Akero Therapeutics in USD5.2bn deal to strengthen MASH pipeline
DarioHealth and OneStep partner to integrate fall risk technology into digital health platform
Renalytix submits CE Mark application for kidneyIntelX.dkd in Europe
Ocular Therapeutix prices USD475m common stock offering
Early, Evidence-Led Cardiovascular Care Strengthened in High-Risk MENA Regions